Part II in a three-part webinar series titled: Process Driven Compliance for a Competitive Advantage – the right approach to lifecycle quality in a new era of regulatory enforcement

Later-Stage Development: Ensuring Compliance During Clinical Trials

As bio pharmaceutical and medical device companies move away from end-to-end ownership of the development cycle, choosing to outsource to multiple partners, how can they ensure compliance across the value chain and avoid liability issues?

Featured speakers from Eli Lilly, Novartis and Quintiles